Search research articles
Contact Us
Filters
Showing results (381-390 of 441) with videos related to
Page
of 45
Sort By:
Gastroenterology
|
November 5, 2013
Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection
Gregory T Everson, Karen D Sims, Maribel Rodriguez-Torres, et al.
Elife
|
November 17, 2015
Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients
Cécile Alanio, Francesco Nicoli, Philippe Sultanik, et al.
Blood
|
September 9, 2016
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Luca Arcaini, Caroline Besson, Marco Frigeni, et al.
The New England Journal of Medicine
|
June 24, 2011
Telaprevir for retreatment of HCV infection
Stefan Zeuzem, Pietro Andreone, Stanislas Pol, et al.
Hepatology (Baltimore, Md.)
|
December 20, 2011
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes
Pierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, et al.
Cytokine
|
May 4, 2021
Differential levels of IFNα subtypes in autoimmunity and viral infection
Vincent Bondet, Mathieu P Rodero, Céline Posseme, et al.
Journal of Hepatology
|
October 11, 2015
Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection
Stefan Zeuzem, Christophe Hézode, Jean-Pierre Bronowicki, et al.
American Journal of Hematology
|
November 25, 2014
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study
Jean-Marie Michot, Danielle Canioni, Henda Driss, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 26, 2019
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study
Tarik Asselah, Stanislas Pol, Christophe Hezode, et al.
Alimentary Pharmacology & Therapeutics
|
August 16, 2021
Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes
Thierry Poynard, Valérie Paradis, Jimmy Mullaert, et al.
Page
of 45
Search research articles
Search
Showing results (381-390 of 441) with videos related to
Sort By:
Page
of 45
Gastroenterology
|
November 5, 2013
Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection
Gregory T Everson, Karen D Sims, Maribel Rodriguez-Torres, et al.
Elife
|
November 17, 2015
Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients
Cécile Alanio, Francesco Nicoli, Philippe Sultanik, et al.
Blood
|
September 9, 2016
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Luca Arcaini, Caroline Besson, Marco Frigeni, et al.
The New England Journal of Medicine
|
June 24, 2011
Telaprevir for retreatment of HCV infection
Stefan Zeuzem, Pietro Andreone, Stanislas Pol, et al.
Hepatology (Baltimore, Md.)
|
December 20, 2011
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes
Pierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, et al.
Cytokine
|
May 4, 2021
Differential levels of IFNα subtypes in autoimmunity and viral infection
Vincent Bondet, Mathieu P Rodero, Céline Posseme, et al.
Journal of Hepatology
|
October 11, 2015
Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection
Stefan Zeuzem, Christophe Hézode, Jean-Pierre Bronowicki, et al.
American Journal of Hematology
|
November 25, 2014
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study
Jean-Marie Michot, Danielle Canioni, Henda Driss, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 26, 2019
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study
Tarik Asselah, Stanislas Pol, Christophe Hezode, et al.
Alimentary Pharmacology & Therapeutics
|
August 16, 2021
Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes
Thierry Poynard, Valérie Paradis, Jimmy Mullaert, et al.
Page
of 45